A single-session pain management class results in clinically significant improvements in pain intensity in chronic low back pain.
The application is supported by data from the phase 3 SPIRIT program, which includes the SPIRIT 1 and SPIRIT 2 studies, as well as an open-label extension study.
The phase 3 RALLY study is evaluating the efficacy and safety of TNX-102 SL in 514 adult patients with fibromyalgia.
Data are lacking on the effectiveness of acupuncture in alleviating pain post total knee replacement.
A Weill Cornell Medicine team analyzed Health Care Cost Institute database claims, with opioid prescription gaps ≥30 days considered long-term nonuse.
For women with pain after urogynecological mesh insertion, symptoms are often not improved by mesh removal.
The researchers’ goal was to provide the initial evidence for the safety and efficacy of sublingual ketamine in patients with chronic nonmalignant pain.
Considerable uncertainty exists about the clinical efficacy and safety of muscle relaxants for the treatment of low back pain.
Researchers presented a study protocol for a trial evaluating the efficacy of 3 forms of virtual reality interventions for patients with highly prevalent chronic lower back pain.
The researcher’s goal was to compare the impact of symptoms, along with health care utilization of those diagnosed with fibromyalgia, those who fulfill the criteria but are undiagnosed, and those with chronic pain.